The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial being presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical
Drug Shows Activity Against Brain Metastases
Related with "Drug Shows Activity Against Brain Metastases"
Breast Cancer and Brain Metastases Survival Is…
Breast Cancer and Brain Metastases - Survival Is as Expected April 4th, 2007 BMC Cancer. 2007 Mar 26;7(1):53 [Epub ahead of print] Related Articles… Breast Cancer and Brain Metastases Survival Is...[...]
New Drug May Increase Breast Cancer Survival
New research shows that a new drug called an aromatase inhibitor may boost the survival rate of post menopausal women who suffer from breast cancer… New Drug May Increase Breast Cancer Survival[...]
Genes predict metastases
Today in the Journal Nature it is reported that there is a panel of four genes that when expressed enable breast cancer cells to metastasize to the… Genes predict metastases[...]
BRITISH BAN ON EXPENSIVE DRUG OVERTURNED Health…
Health regulators have overturned a ban on two drugs that could benefit patients suffering from rare and life-threatening brain cancers. The revised… BRITISH BAN ON EXPENSIVE DRUG OVERTURNED Health...[...]
Brain Tumor
A brain tumor is any mass created by an abnormal and uncontrolled growth of cells either found in the brain (neurons, glial cells, epithelial cells, myelin producing cells, etc.) or spread from elsewhere (metastasis). Brain tumors are usually located in the posterior third of the brain in childhood and in[...]
